01 Chloramphenicol and tetracycline products: Chloramphenicol and tetracycline products have shown an overall stable trend.
Fluoroquinolone, during the first week of March, had a market price ranging from 155 to 165, maintaining a stable low level. Compared to the previous week, the price remained basically unchanged, but decreased by 15.9% and 21.3% compared to 2025 and 2024 respectively. The average transaction price in the first quarter of this year was below 160, with a lukewarm market transaction atmosphere. There were few support points for the market to rise in March. Asia-Pacific Easy and Data Analysis Research Institute focused on this product.
Thiamphenicol has a stable market situation, with a market price of 170. The month-on-month decrease is 0.6%, and the year-on-year decrease is 12.6%. The average prices for the same period in the past three years from 2025 to 2023 were 197, 235, and 303 respectively. The market trend in March is stable.
Doxycycline hydrochloride, with a market price range of 303-319, has undergone volatile adjustments in the market, with a significant wait-and-see attitude prevailing.
Oxytetracycline, oxytetracycline hydrochloride. The market price range for oxytetracycline is 73-85, with a month-on-month decrease of 0.3% and a year-on-year increase of 1.1%. For oxytetracycline hydrochloride, the market price range is 95-105, with a month-on-month decrease of 0.4% and a year-on-year increase exceeding 5%. The average prices for the same period in the past five years from 2025 to 2021 are 95, 93, 97, 106, and 114 respectively. The market experienced volatile consolidation in March, with significant downward pressure.
Chlortetracycline hydrochloride, with a market price of 149, remained basically unchanged compared to last week's price, with a year-on-year decrease of 14.8%.
02 Penicillins and cephalosporins Both penicillins and cephalosporins products are operating smoothly overall.
Amoxicillin and amoxicillin sodium. Amoxicillin has a transaction price range of 169-179; amoxicillin sodium has a market price of 300-355.
Amoxicillin and clavulanate potassium are operating weakly, with a market price ranging from 465 to 495. The month-on-month decrease is 0.5%, while the year-on-year decrease exceeds 20%.
Ampicillin, with a market price range of 169-179, saw a month-on-month decrease of 0.3% and a year-on-year decrease of over 20%. The market trend in March remained stable.
Ampicillin sodium, with a relatively weak performance, has a market price ranging from 275 to 315. It has decreased by 0.2% month-on-month and 15.3% year-on-year.
Penicillin sodium, with a market price range of 100-115/billion, has seen a month-on-month decrease of 0.3% and a year-on-year decrease of over 30%. The market trend in March is downward.
The market for penicillin potassium industrial salt has been stable with a slight decline, trading within a range of 60-70/billion. Compared to last week's prices, there has been essentially no change, with a narrowed decline. The trading market has seen an increase in brands, offering ample bargaining space for bulk transactions.
Ceftiofur sodium, cefotiofur hydrochloride, and ceftiofur sulfate, with different levels of sterility and non-sterility, have a wide price range. Ceftiofur sodium, which is relatively weak in performance, has a market price of around 800; cefotiofur hydrochloride has a market price of 770-870; and ceftiofur sulfate has a market price of 3800-4180, which is basically unchanged compared to last week's price, with a year-on-year decrease of 15.6%. The average prices for the same period in the past five years from 2025 to 2021 were 4920, 5600, 6190, 6900, and 8000, respectively.
All rights reserved by the original article of Asia-Pacific Easy and Data Analysis Research Institute. The market data analysis is for the comprehensive price of bulk products and is not used as a basis for investment.
03 Aminoglycosides
Aminoglycoside products have been performing weakly overall.
Neomycin sulfate, with a market price of 145-155/billion, has seen a month-on-month decrease of 0.3% and a year-on-year decrease of 6.1%. The average prices in March for the past three years from 2025 to 2023 were 162, 142, and 145 respectively.
Spectinomycin dihydrochloride (sulfate) has seen an easing of supply, with a market price ranging from 535 to 555. This represents a month-on-month decrease of 2.1% and a year-on-year decrease of 6.9%. Transaction prices vary significantly depending on the region and brand. The price has been continuously falling for over twenty weeks, indicating a weak trend in the market in March.
Streptomycin sulfate, with a price range of 265-305 yuan/billion, remains unchanged compared to last week's price, but the unit price has decreased by 20 yuan compared to the same period last year.
Amprolium sulfate, with a market price of 189-199, remains unchanged compared to last week's price. The transaction prices for the same period in 2025 and 2024 were higher than 200, indicating a strong market trend in March.
Kanamycin monosulfate, with a market transaction price of 295/billion, saw a month-on-month increase of 0.4%, while the year-on-year transaction price remained unchanged. The market trend in March was relatively strong.
Amikacin sulfate, with a market price of 745, has seen a month-on-month decrease of 0.3%, and a decline of nearly 100 yuan per unit compared to the same period last year. The market trend in the first quarter remains stable.
Gentamicin sulfate, with a market price of 1050-1200/billion, remains basically unchanged compared to last week's market conditions, and the market trend in March is stable.
04 The overall market trend for macrolides and other antibiotic macrolide products is weak.
Tylosin Tartrate, with a market price of 265-285, has declined compared to last week's market, with a year-on-year increase of over 20%. It has been continuously falling for over 3 months. The average prices for the same period in 2025, 2023 were 228, 223, and 275 respectively. It is a key focus product of the Asia-Pacific Easy and Data Analysis Research Institute.
Tilmicosin and tilmicosin phosphate. The market price of tilmicosin is 335-350, with a month-on-month decrease of 1.3% and a year-on-year increase of over 20%; the market price of tilmicosin phosphate is 285-315, with a month-on-month decrease of 2.2% and a year-on-year increase of 11.9%.
Kitasamycin Tartrate, with a market price of 355, has shown a weak trend in March.
Tylvalosin tartrate, with a trading market price of 380-399, has seen a month-on-month decrease of 2.3% and a year-on-year increase of 4.1%. The market trend in March is relatively weak.
Tylosin, with a relatively weak operational performance, has a market price of 6700.
Erythromycin thiocyanate, with a market price range of 455-495, saw a month-on-month decrease of 2.1% and a year-on-year decrease of 4.5%. The market trend in March was stable with a slight decline.
Sulfate colistin, operating smoothly, with a market price of 110-115.
Tylosin fumarate, after consolidation through volatility, has a market price of 245-255, with a month-on-month increase of 0.6% and a year-on-year increase of over 10%.
Lincomycin hydrochloride has a stable market situation, with a market price ranging from 319 to 339 yuan per billion. The month-on-month decrease is 0.5%, and the unit price has dropped by nearly 100 yuan compared to the same period last year.
Original article from Asia-Pacific Easy and Data Analysis Research Institute. Reproduction without permission is prohibited. Infringement will be prosecuted. For reproduction and quotation, please contact the author and indicate the original source.
05 Quinolones
The market for quinolones has undergone volatile adjustments.
Enrofloxacin and enrofloxacin hydrochloride. The market price is 165, with little change compared to last week's market situation. However, it has decreased by over 10% compared to the same period last year, and the market trend is expected to rise in March.
Ciprofloxacin lactate (hydrochloride) has a price of 160, with a stable market trend. Compared to last week, its price has slightly increased, while it has decreased by 11.3% compared to the same period last year. The average prices from 2025 to March 2023 were 178, 189, and 225 respectively.
Sarafloxacin hydrochloride has a stable market situation, with a current market price of 390.
Mapofloxacin, with a market price of 2300, has seen a month-on-month decrease of 1.3% and a year-on-year decrease of 17.8%.
06 Sulfonamides
The prices of sulfa products remain firm, with a slightly tight supply side.
Sulfamethoxazole (sodium) continues to perform strongly in the market, with transaction prices ranging from 189 to 239. The average prices for the years 2025, 2024, and March 2023 were 205, 212, and 280, respectively.
Sulfamethoxazole (sodium), market price 235.
Sulfamethoxazole (sodium), with a price range of 100-145, has been performing strongly in the market in March.
Sulfadiazine (sodium) has a stable market situation, with a market price of 155. The average prices from 2025 to March 2023 were 165, 154, and 205 respectively.
Sulfamethazine (sodium) has a market price of 99, which is basically unchanged from last week's market situation, with a year-on-year increase of 24.4%. The average prices from 2025 to March 2023 are 87, 81, and 98 respectively.
Sulfamethoxazole sodium, with a market price of 195, remains basically unchanged compared to last week's price, but has increased by more than 20% year-on-year. The average prices from 2025 to March 2023 were 171, 181, and 305 respectively.
Sulfamethoxazole and Chlorphenamine Sodium, with a market price of 215, had average prices of 214, 233, and 319 in March 2023, 2024, and 2025, respectively.
Sulfachloropyridazine sodium, with a market price range of 175-195, has seen an increase compared to the previous week's market, with a year-on-year increase of 2.3%. The average prices from 2025 to March 2023 were 173, 140, and 177 respectively.
Dimethoprim, stable trend, market price 380.
Trimethoprim, trimethoprim lactate. Trimethoprim, market price 239; trimethoprim lactate, market price 190.
07 Antiparasitic drugs
The market for some antiparasitic products has seen an increase.
Abendazole, with relatively strong performance, has a market price range of 125-135, with a month-on-month increase of 0.2% and a year-on-year decrease of over 10%.
Fenbendazole, with relatively strong performance, has a market price of 230, with a month-on-month increase of 1.3% and a year-on-year decrease of 12.3%.
Avermectin, operating at a slightly weak level, trades at a price of 530-610.
Ivermectin, with a relatively weak performance, has a market price of 760. The average prices for the same period in the past five years from 2025 to 2021 were 789, 852, 1092, 1460, and 1410 respectively. The average price over the past three years has been below 900, and the average price in 2025 was below 800.
Diclazuril, with a market price of 980, has declined compared to last week's market, with a year-on-year decrease of 3.1%.
Tuoqu Zhuli, with strong performance, has a market price of 840.
Levamisole hydrochloride, with relatively strong performance, has a market price range of 335-355, with a month-on-month increase of 0.7% and a year-on-year increase of over 10%.
Amprolium hydrochloride, with a market price of 330, has seen an upward trend in March.
Metronidazole, with a market price of 80, has seen a month-on-month decrease of 0.4% and a year-on-year decrease of 4.1%. The average prices for the same period from 2025 to 2023 were 80, 78, and 84 respectively, with an upward trend in March.
Demenidazole, with a market price of 100, remained basically unchanged compared to last week's price, with a year-on-year increase of 6.7%. The average prices for the same period from 2025 to 2023 were 89, 99, and 147 respectively.
Praziquantel, with a market price of 310, remains basically unchanged compared to last week's price, but the unit price has decreased by nearly 100 yuan compared to the same period last year, showing an upward trend in March.
Cyromazine, with a market price of 100, has been performing strongly in March.
To learn more, please join the Asia-Pacific Yihe Data Analysis Research Institute as a member to stay updated on market changes in real-time.
08 Products for fever relief, pain relief, asthma relief, and immunity enhancement
The overall trend of antipyretic and analgesic products remains stable.
Flunixin meglumine has a stable market situation, with a market price range of 369-379. It has increased by 0.3% month-on-month, but decreased by more than 10% year-on-year.
Metamizole sodium, with a market price of around 80, has seen a month-on-month increase of 1.4% and a year-on-year decrease of 3.1%.
Acetaminophen, with relatively strong performance, has a market price of 24, slightly higher than last week's market situation, and a year-on-year decrease of 4.9%.
Aminopyrine, with a market price of 100, has remained stable compared to last week's market conditions, with a year-on-year decrease of 2.9%.
Aminophylline, market price 105.
Aspirin, operating at a relatively weak level, has a market price of 18,900/ton.
Taurine, with its market situation stabilizing, has a market price of 15,300/ton, a month-on-month decrease of 1.5%, and a year-on-year increase of 18.9%. The tonnage prices for the same period from 2025 to 2023 were 12,500, 16,700, and 24,200, respectively.
Carbasalate calcium, adjusted for fluctuations, has a market transaction price of 29. The average prices for the past three years, from 2025 to 2023, are 42, 34, and 37 respectively. The price began to rise at the end of January in the first quarter of last year, with an increase of over 30% in the first quarter.
09 Veterinary drug excipients and other categories
Acetylmethaquine, with a market price range of 40-50, is experiencing volatile market consolidation.
Sodium camphor sulfonate, market price 56, with an upward trend in March.
Chlorpheniramine, with a market price of 150, saw a month-on-month increase of 1.3% and a year-on-year decrease of 14.3%. The market trend in March remained stable.
Sodium salicylate, with a rising market trend, is trading at a price of 26,100/ton.
Citric acid, with the market price rising, is currently priced at 4460/ton.
Sodium citrate has been steadily increasing, with a market price of 4550/ton.
Sodium carbonate, with a stable yet slightly declining market, has a market price of 2160/ton.
Sodium bicarbonate, with a stable yet declining market, has a market price of 2410/ton.
Glucose, trading price 3700-6200/ton.
Jiayi powder, trading price 2600-3200/ton.
Soluble starch, with a market price of 12,400/ton, is showing a weakening trend.
Beta-cyclodextrin, with a market price of 18,200/ton, is showing a weakening trend.
10 Plant-derived Chinese herbal medicines
The overall trend of plant-based traditional Chinese medicinal materials remains stable.
Shuanghuanglian extract, 50-80.
Astragalus polysaccharide extract, 49-110.
Scutellaria baicalensis extract, 110-140.
Licorice extract, 60-95.
Honeysuckle extract, 48-110.
Honeysuckle, 60-110.
Huanglian, 240-290.
Astragalus, 7-12.
Scutellaria, 22-29.
Yanhusuo, 55-65.
Chenpi, 10-13.
Hawthorn, 4.5-10.
Licorice, 19-30.
Dried ginger, 16-25.
Safflower, 62-80.
Banlangen, 18-29.
11 Vitamins
Vitamin products are experiencing volatile consolidation.
VA, with stable market conditions, has a mixing ratio of 60-65 and a water solubility of 85.
VB1, market stable, nitric acid 235, hydrochloric acid 290.
VB2, 98% purity priced at 270, 80% purity priced at 66.
VB6, with a stable market, has a market price of 108.
VB12 1%, market price around 90, with a stable market trend.
VC, the market quotation is around 20 for feed grade and 27 for pharmaceutical grade.
VD3, market price for mixing materials is 120, water solubility is 130, showing a downward trend.
VE, oscillating downward, mixing ratio 56, water solubility 95.
VK3, with a market price of 72, has seen a steady increase.
Calcium pantothenate, stable operation, market price 42.
Nicotinamide, with a market price of 46, has seen a volatile upward trend.
Biotin 2%, market price 33.
Folic acid, market price 380.
